Evaluating age as a factor for survival and quality of life in patients with BRAF V600E-mutant metastatic colorectal cancer treated with encorafenib + cetuximab ± binimetinib: Subanalysis of BEACON CRC Meeting Abstract


Authors: Ng, K.; Ciardiello, F.; Van Cutsem, E.; Yaeger, R.; Yoshino, T.; Desai, J.; Wasan, H.; Alkuzweny, B.; Zhang, X.; Tabernero, J.; Kopetz, S.
Abstract Title: Evaluating age as a factor for survival and quality of life in patients with BRAF V600E-mutant metastatic colorectal cancer treated with encorafenib + cetuximab ± binimetinib: Subanalysis of BEACON CRC
Meeting Title: ESMO 24th World Congress on Gastrointestinal Cancer 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 4
Meeting Dates: 2022 Jun 29-Jul 2
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-06-01
Start Page: S372
End Page: S373
Language: English
ACCESSION: WOS:000823826500355
DOI: 10.1016/j.annonc.2022.04.435
PROVIDER: wos
Notes: Meeting Abstract: SO-37 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger